アライアンサ・アマーテ:ブラジルにおける小児がん治療の改善のための協力ネットワーク
Luiz Fernando Lopes1,2, Patrícia Loggetto2, André de Oliveira Junior1
1Hospital De Câncer Infantojuvenil De Barretos, Barretos, São Paulo, Brazil.
Pediatric blood & cancer
|September 4, 2025
まとめ
AMARTEアライアンスでは 協働を通じて ブラジルの小児がん治療を改善しました このネットワークは 持続的な参加とガバナンスにおける課題にもかかわらず 診断,治療,研究を強化しました
科学分野:
- 小児腫瘍学
- 健康に関する公平性
- 協力ネットワーク
背景:
- ブラジルでは 子どものがん治療へのアクセスと生存率に 地域差が大きい.
- 2014年に6つの病院で始まったAMARTEアライアンスでは, 2024年までに31の機関に拡大しました.
- この提携は,全国で小児がん治療の質を向上させることを目的としています.
研究 の 目的:
- ブラジルの小児がん治療の協力ネットワークを確立する.
- 地理的な地域における診断と治療の格差に対処する.
- 子どものがん治療におけるイノベーション,研究,専門的な訓練を推進する.
主な方法:
- AMARTEアライアンスには4つの柱があります 診断の均等化,治療の標準化,生存研究の実施,科学的発展の促進です
- インフラと人材はFundação Pio XIIとSt. Jude Children's Research Hospitalによってサポートされています.
- 半年に一度の評価 (SCORE) は,定義された指標を用いてメンバーの進歩と関与をモニターします.
主要な成果:
- 3つの取り組みレポートでは 17の病院が スコアを向上させています
- 主要な成果は,共有データレジストリ,標準化されたプロトコル,定期的な科学会議,専用の資金調達グループです.
- イノベーションと学習のための協力的な環境を育成しました.
結論:
- AMARTEアライアンスでは,小児腫瘍学の進歩における協力の重要な役割を示しています.
- 専門家の継続的な参加を保証し,多様なガバナンス構造を操作するには,依然として課題があります.
- 成果の指標を策定することは,同盟の長期的な影響を評価する上で極めて重要です.
さらに関連する動画
11:18Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
16.2K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.6K
関連する概念動画
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Chronic Kidney Disease III: Interprofessional Care
77
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
77
